Alıntılar

APA (7. basım) Alıntı
Cooper, N., Guterres, S., Pochopień, M., Wilson, K., James, S., Toumi, M., . . . Eriksson, D. (2025). The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK. MDPI AG.
Chicago Style (17. basım) Atıf
Cooper, Nichola, Sebastian Guterres, Michał Pochopień, Koo Wilson, Sam James, Mondher Toumi, Anna Tytuła, Carly Rich, ve Daniel Eriksson. The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK. MDPI AG, 2025.
MLA (9th ed.) Atıf
Cooper, Nichola, et al. The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK. MDPI AG, 2025.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..